Department of Gynecology, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
Department of Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Cancer Med. 2024 Feb;13(3):e6875. doi: 10.1002/cam4.6875. Epub 2024 Jan 11.
Cervical cancer (CC) has become the fourth most common cancer worldwide and it is mainly caused by the infection of human papillomavirus (HPV), especially high-risk HPV16. Aberrant miRNA expression in CC is closely related to HPV16 infection, and the regulation of HPV16 E6 expression can affect a variety of miRNA expression. This study aims to exploring the miRNAs involved in E6 regulation in CC.
Our study screened differentially expressed miRNAs in cervical cells of HPV16 infected and uninfected cervical cancer patients by analyzing the GSE81137 dataset of the gene expression omnibus database (GEO), and identified miR-320a that plays an anti-tumor role and is associated with good prognosis of cervical cancer. Explore the effect of HPV16 E6 on the expression of miR-320a in cervical cancer, and verify whether HPV16 E6 regulates the downstream target gene TOP2A expression through miR-320a, thereby affecting cervical cancer cell proliferation, apoptosis, migration, invasion, and EMT in vitro and in vivo.
The bioinformatic methods selected the miR-320a, which was differentially expressed in cervical cells from HPV16-infected patients compared to uninfected patients. We further demonstrated that miR-320a level was regulated by HPV16 E6, which promoted the CC cell proliferation, migration, invasion, and inhibited apoptosis. In addition, we predicted the downstream target genes of miR-320a and confirmed that TOP2A was one of its targeting proteins. Moreover, HPV16 E6 promoted the TOP2A expression in CC cells through down-regulating miR-320a, leading to promoting CC development.
We confirmed that HPV16 E6 promoted the TOP2A expression through down-regulation of miR-320a, thus promoting CC development, and the HPV16 E6/miR-320a/TOP2A axis may perform as a potential target for CC treatment.
宫颈癌(CC)已成为全球第四大常见癌症,主要由人乳头瘤病毒(HPV)感染引起,尤其是高危型 HPV16。CC 中异常的 miRNA 表达与 HPV16 感染密切相关,HPV16 E6 的调控可影响多种 miRNA 的表达。本研究旨在探讨 HPV16 调控 CC 中涉及的 miRNA。
我们通过分析基因表达综合数据库(GEO)的 GSE81137 数据集,筛选出 HPV16 感染和未感染宫颈癌患者宫颈细胞中差异表达的 miRNA,发现 miR-320a 具有抗肿瘤作用,与宫颈癌的良好预后相关。探讨 HPV16 E6 对宫颈癌中 miR-320a 表达的影响,验证 HPV16 E6 是否通过 miR-320a 调节下游靶基因 TOP2A 的表达,从而影响宫颈癌细胞在体外和体内的增殖、凋亡、迁移、侵袭和 EMT。
生物信息学方法选择了 HPV16 感染患者宫颈细胞中与未感染患者相比差异表达的 miR-320a。我们进一步证明,miR-320a 水平受 HPV16 E6 调控,促进 CC 细胞增殖、迁移、侵袭,抑制凋亡。此外,我们预测了 miR-320a 的下游靶基因,并证实 TOP2A 是其靶向蛋白之一。此外,HPV16 E6 通过下调 miR-320a 促进 CC 细胞中 TOP2A 的表达,从而促进 CC 的发展。
我们证实 HPV16 E6 通过下调 miR-320a 促进 TOP2A 的表达,从而促进 CC 的发展,HPV16 E6/miR-320a/TOP2A 轴可能作为 CC 治疗的潜在靶点。